Full Compliance of Adjuvant Endocrine Therapy Is Associated with Higher Disease-Free Survival in Hormone Receptor-Positive and HER2-Negative Chinese Breast Cancer Patients with First Tumor Recurrence

PURPOSE: To characterize the compliance status of adjuvant endocrine therapy (aET) and its relationship with disease-free survival (DFS) in hormone receptor-positive (HR+) and HER2-negative (HER2−) in Chinese breast cancer (BC) patients with first tumor recurrence. METHODS: All women with primary un...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhensheng, Liu, Yunjiang, Li, Yue, Shang, Yuguang, Du, Kaiye, Ji, Xiaohui, Han, Huina, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924327/
https://www.ncbi.nlm.nih.gov/pubmed/36308366
http://dx.doi.org/10.31557/APJCP.2022.23.10.3413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924327/
https://www.ncbi.nlm.nih.gov/pubmed/36308366
http://dx.doi.org/10.31557/APJCP.2022.23.10.3413

Ejemplares similares